Electromedical Technologies, Inc (EMED) stock
Close on Oct 19, 2026Market cap $68.10KP/E –Yield –
Electromedical Technologies, Inc saw revenue fall 35.1% to $922.01K over the twelve months to Sep 30, 2024. Free cash flow was -$1.57M. At the latest close the market valued the company at $68.10K.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2024
Valuation
- Market cap
- $68.10K
- P/E ratio
- –
- Price to sales
- 0.07
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -2301.17%
Fundamentals
- Revenue
- $922.01K
- Net income
- -$1.68M
- EPS, diluted
- -$0.00
- Free cash flow
- -$1.57M
- Book value per share
- -$0.01
- Diluted shares
- 681M
Trading
- Previous close
- $0.00
- Open
- $0.00
- Day's range
- $0.00 – $0.00
- Volume
- 9,850,000
- Average volume (20 days)
- 6,924,992
Market cap history
Month-end market cap since 2020, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | EMED | S&P 500 | Difference | EMED per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | 0.0% | +0.6% | −0.6 pts | ||
| 3 months | 0.0% | +3.4% | −3.4 pts | ||
| Year to date | -50.0% | +13.3% | −63.3 pts | ||
| 1 year | 0.0% | +16.6% | −16.6 pts | ||
| 3 years | -85.7% | +86.4% | −172.1 pts | -47.7% | +23.1% |
| 5 years | -99.9% | +81.9% | −181.8 pts | -76.4% | +12.7% |
Six years at a glance
Fiscal years 2018 to 2023 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
About Electromedical Technologies
Surgical & Medical Instruments & Apparatus
Electromedical Technologies manufactures and markets bioelectronic medical devices designed for drug-free pain relief. Its flagship product is the WellnessPro Plus, an FDA-cleared transcutaneous electrical nerve stimulation device that delivers proprietary electrical frequencies to manage chronic and acute pain conditions. The business also develops additional bioelectric products, such as the WellnessPro POD wearable and the Wellness ION Pen cold-laser system. Its products serve individual consumers and healthcare practitioners, including chiropractors, physiotherapists, and specialists in pain management, natural medicine, and sports medicine.
Company profile, executives and historyElectromedical Technologies stock: common questions
What is Electromedical Technologies's stock price?
EMED closed at $0.00 on Oct 19, 2026, up 9900.00% on the day.
What is Electromedical Technologies's market cap?
Electromedical Technologies was worth $68.10K at the close on Oct 19, 2026: the share price times the diluted shares outstanding.
What is EMED's P/E ratio?
Electromedical Technologies lost money over the twelve months to Sep 30, 2024 (diluted EPS -$0.00), so it has no meaningful P/E ratio.
How much revenue does Electromedical Technologies make?
Electromedical Technologies reported revenue of $922.01K for the twelve months to Sep 30, 2024, down 35.1% from a year earlier.
Does Electromedical Technologies pay a dividend?
No. Electromedical Technologies has not paid a cash dividend over the last twelve months.
How has EMED stock performed over the past year?
Including dividends, EMED returned 0.0% over the past year, against +16.6% for the S&P 500.
Who are Electromedical Technologies's competitors?
Companies most similar to Electromedical Technologies by business, industry and size include STME, NMTC, SNWV, SNOA, TCMD.
See a number that looks wrong?